Paragraph IV Patent Challenges: How Generic Drug Makers Beat Brand Patents
Paragraph IV patent challenges let generic drug makers legally fight brand drug patents before they expire. This system, created by the Hatch-Waxman Act, saves consumers billions and drives 90% of U.S. prescriptions to generics.
View more